$PCYC News Biotech hammered as ETFs down 5%, while some

New Post Public Reply Private Reply Replies (0) Message Board

Jul 29, 2014 at 11:51 AM

$PCYC News

Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 1:13 p.m. April 8, 2014 - Russ Britt
S&P 500’s slow-motion breakout attempt ‘rages on’ 12:43 p.m. Feb. 27, 2014 - Michael Ashbaugh
FDA approval of leukemia treatment boosts shares of Pharmacyclics 2:57 p.m. Feb. 12, 2014 - Russ Britt
Pharmacyclics shares soar after panel says cancer drug met goals 1:09 p.m. Jan. 7, 2014 - Russ Britt
Gilead, Acura stand out on up day for stocks, Quest tumbles 11:27 a.m. Oct. 10, 2013 - Russ Britt
Health care leads S&P as St. Jude gets some good news from FDA 11:49 a.m. Oct. 4, 2013 - Russ Britt
Rough market day for Nektar, while Pharmacyclics and Regeneron soar 6:21 p.m. Sept. 26, 2013 - Russ Britt
Pharmacyclics shares jump after FDA accepts new cancer drug filing 12:09 p.m. Aug. 29, 2013 - Russ Britt
S&P 500 ventures to uncharted territory 12:21 p.m. July 18, 2013 - Michael Ashbaugh
Pharmacyclics seeks fast-track drug approval, makes double-digit gain 11:09 a.m. July 10, 2013 - Russ Britt
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
Positives continue to build for the Nasdaq 1:31 p.m. June 4, 2013 - The Trading Deck
For the medium-term trader, setups galore 11:39 a.m. May 14, 2013 - The Trading Deck
After the close: Big gains for Pharmacyclics, Biogen, Warner 5:39 p.m. May 13, 2013 - Russ Britt
FDA gives 'breakthrough' designation to Merck drug 9:10 p.m. April 23, 2013 - MarketWatch.com
Quest Diagnostics shares climb on glowing words from Goldman 12:26 p.m. April 11, 2013 - Russ Britt
Nasdaq clues suggest more upward valuation 1:46 p.m. March 8, 2013 - The Trading Deck
Leading stocks strut their stuff 11:39 a.m. March 5, 2013 - The Trading Deck
The return of the European bogeyman 1:58 p.m. Feb. 26, 2013 - The Trading Deck

Undervalued Biotech Stocks Beat the Index 6:54 a.m. Today - Barrons.com
Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog 5:15 p.m. July 28, 2014 - Zacks.com
Can the Rally in Pharmacyclics (PCYC) Shares Continue? - Tale of the Tape 8:37 a.m. July 24, 2014 - Zacks.com
7 Biotechnology Stocks to Buy Now 6:00 a.m. July 23, 2014 - InvestorPlace.com
Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion 2:06 p.m. July 21, 2014 - Seeking Alpha
Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More? 10:40 a.m. July 21, 2014 - Seeking Alpha
4 Top Biotechs Expected to Beat Earnings Expectations 9:17 a.m. July 16, 2014 - 247WallSt.com
7 Biotechnology Stocks to Buy Now 6:30 a.m. July 16, 2014 - InvestorPlace.com
8 Biotechnology Stocks to Buy Now 5:45 a.m. July 9, 2014 - InvestorPlace.com
Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment 8:01 a.m. July 8, 2014 - Seeking Alpha
Pharmacyclics Inc. (PCYC): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. July 3, 2014 - Zacks.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. July 2, 2014 - InvestorPlace.com
Individual Investor Portfolio Update: Diversifying For Growth 1:40 a.m. July 1, 2014 - Seeking Alpha
Credit Suisse Raises Q2 Imbruvica Sales Forecast For Pharmacyclics 8:18 a.m. June 30, 2014 - benzinga.com
7 Biotechnology Stocks to Buy Now 6:30 a.m. June 25, 2014 - InvestorPlace.com
'Fast Money' Recap: A Mixed Bag for Housing 5:00 a.m. June 25, 2014 - TheStreet.com
Cramer's Mad Money - 9 Things To Watch In The Week Ahead (6/20/14) 5:10 a.m. June 22, 2014 - Seeking Alpha
Fire Up The Immuno-Oncology Powerhouses: John McCamant 5:39 p.m. June 19, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 5:45 a.m. June 11, 2014 - InvestorPlace.com
Pharmacyclics' Imbruvica Under FDA Priority Review - Analyst Blog 6:45 p.m. June 10, 2014 - Zacks.com

Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 7:02 p.m. July 28, 2014 - PR Newswire - PRF
U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications 1:18 p.m. July 28, 2014 - PR Newswire - PRF
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) for Treatment of Two Blood Cancers 8:52 a.m. July 25, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Critical Alerts For Intuitive Surgical, Estee Lauder, Dominos Pizza, Pharmacyclics, and Tata Motors Released By InvestorsObserver 9:31 a.m. July 2, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology 7:10 a.m. June 11, 2014 - PR Newswire - PRF
Supplemental New Drug Application for IMBRUVICA® Accepted by the U.S. FDA and Priority Review Granted 8:00 a.m. June 9, 2014 - PR Newswire - PRF
IMBRUVICA® (ibrutinib) Combination with anti CD20 Antibody Shows Compelling Results in Heavily Pretreated Patients with CLL and Related Diseases 8:05 a.m. May 31, 2014 - PR Newswire - PRF
IMBRUVICA® (ibrutinib) Significantly Improves Progression Free Survival, Overall Survival and Overall Response as compared to Ofatumumab in Patients with Previously Treated CLL/SLL in its First Phase III study 8:05 a.m. May 31, 2014 - PR Newswire - PRF
Milestone Payments, Clinical Trial Results, Technical Updates, and Earnings Results - Analyst Notes on Pharmacyclics, Isis, Novo Nordisk, Dr. Reddy's and Orexigen 5:10 a.m. May 29, 2014 - PR Newswire - PRF
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Pharmacyclics appoints Gregory R. Wade to lead Business Development 8:00 a.m. May 20, 2014 - PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics 11:29 a.m. May 19, 2014 - PR Newswire - PRF
Study Results, Analyst Meetings, Upcoming Events, Financial Results, and Welfare Initiatives - Analyst Notes on Pharmacyclics, Thermo Fisher Scientific, Endo, Humana and Aetna 8:00 a.m. May 19, 2014 - PR Newswire - PRF
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF
Pharmacyclics Highlights Important New Data for IMBRUVICA® (ibrutinib) in B-Cell Malignancies 6:22 p.m. May 14, 2014 - PR Newswire - PRF
Pharmacyclics Reports First Quarter 2014 Results 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Pharmacyclics Announces Date of Conference call to discuss Financial Results for First Quarter of 2014 10:45 a.m. April 25, 2014 - PR Newswire - PRF
Pre-market Equity Watch on the Health Care Sector -- Research on Isis Pharma, Pharmacyclics, Novo Nordisk, and Lannett 9:04 a.m. April 22, 2014 - PR Newswire - PRF
Pharmacyclics Announces Presentation of Phase III and Long Term Follow Up Data on IMBRUVICA™ in Chronic Lymphocytic Leukemia (CLL) at ASCO 11:45 a.m. April 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aiper’s Black Friday Pool Deals Make a Splash

Black Friday: A Pool Owner's Break It’s not every day you stumble upon savings like these—Aiper is throwing some meaty discounts this Black Friday, saving pool owners up to a juicy $550 off robotic cleaners. Imagine that! For anyone with a pool to maintain, these deals might just be the ticket to less grunt work and more time lounging with a cold drink in hand....

Extend Your Water Heater's Life with Anode Care

Small Component, Big Impact: The Anode Rod Picture this: You’ve got a trusty water heater keeping your showers steamy, but lurking inside is a villain called rust. Enter the unsung hero—the anode rod. It might not be glamorous, but this little piece of metal works overtime to save your tank from a watery grave. Tim Fessler and Dave Super, seasoned plumbing hotshots...

Can AI Help Climate? Tech Investments Seek Balance

Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...

Why Accurate HVAC Load Calculations Matter

Beyond Square Footage: Critical HVAC Considerations When it comes to heating and cooling your home, simply considering its square footage is like trying to predict the weather with nothing but a coin flip. Bob Schmid, an HVAC guru from Ocean View, NJ, pulls back the curtain on why the details really matter in determining the most efficient and effective HVAC setup for any...

Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Decoding LRV: Smart Paint Choices for Your Home

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

Ensuring Flooring Stability: Acclimation's Key Role

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

Mastering Progressive Overload: Break Workout Plateaus

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...